Etrasimod: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Etrasimod. Educational only — not medical advice.
Labeled uses
VELSIPITY is indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults.
Source: FDA labeling via NIH DailyMed (set 65171e4a…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.